Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Bacterial infections

Risk of drug-resistant sepsis raised for three years after bacteria exposure

Patients can be 50 to 100 times more likely to get a blood stream infection in the years after Enterobacteriaceae is detected in faeces and urine, study results suggest.

People who have been exposed to Enterobacteriaceae (EPE), a family of drug-resistant bacteria, are known to have an increased risk of subsequent sepsis. However, little is known about how this risk changes over time.

Swedish researchers analysed national data to compare 22,702 individuals who had documented EPE in their faeces or urine with a control cohort with no known EPE exposure.

Over a maximum follow-up of six years, people were 57 (hazard ratio [HR] 57.43, 95% confidence interval [CI] 17.41–189.42) and 113 (HR 113.11, 95% CI 35.93–356.10) times more likely to develop an EPE bloodstream infection when EPE was detected in the faeces and urine, respectively, compared with controls. The risk declined exponentially in the first six months after EPE detection, but was still elevated after three years.

The researchers, who presented their findings at the European Congress of Clinical Microbiology and Infectious Diseases in Vienna[1], say they could help doctors diagnose drug-resistant sepsis and inform antibiotic selection.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2017.20202839

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • FASTtrack: Pharmacology

    FASTtrack: Pharmacology

    FASTtrack: Pharmacology is a study guide providing an account of drug action, as well as dealing with molecular pharmacology at a more advanced level.

    £25.00Buy now
  • Introduction to Pharmaceutical Calculations

    Introduction to Pharmaceutical Calculations

    Introduction to Pharmaceutical Calculations is an essential study aid for pharmacy students. The book contains worked examples and sample questions and answers.

    £33.00Buy now
  • Drugs in Use

    Drugs in Use

    Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.

    £43.00Buy now
  • Sport and Exercise Medicine for Pharmacists

    Sport and Exercise Medicine for Pharmacists

    All the information you need to provide patients with evidence-based advice on sports and exercise related health matters.

    £27.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • 3D illustration of enterobacteriaceae

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.